Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;46:51-57
Published online before print May 31, 2005, doi: 10.1161/01.HYP.0000168926.44648.ed
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
46/1/51    most recent
01.HYP.0000168926.44648.edv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bowers, M. C.
Right arrow Articles by Supowit, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bowers, M. C.
Right arrow Articles by Supowit, S. C.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Hazardous Substances DB
*SODIUM CHLORIDE
Related Collections
Right arrow Cardio-renal physiology/pathophysiology
Right arrow Animal models of human disease
Right arrow Other hypertension

(Hypertension. 2005;46:51.)
© 2005 American Heart Association, Inc.


Original Articles

Role of Calcitonin Gene-Related Peptide in Hypertension-Induced Renal Damage

Mark C. Bowers; Khurshed A. Katki; Arundhati Rao; Michael Koehler; Parag Patel; Alvin Spiekerman; Donald J. DiPette; Scott C. Supowit

From Texas A&M University System Health Science Center, College of Medicine and Scott & White Health System, Department of Medicine (M.C.B., K.A.K., M.K., D.J.D., S.C.S.), Temple, Tex; Scott & White Health System (A.R., P.P., A.S.), Department of Pathology, Temple, Tex.

Correspondence to Scott Supowit, Texas A&M University Medical Research Building, 702 SW H.K. Dodgen Loop, Temple, TX 76504. E-mail ssupowit{at}swmail.sw.org

Calcitonin gene-related peptide, a potent vasodilator neuropeptide, is localized in perivascular sensory nerves. We have reported that {alpha}-calcitonin gene-related peptide knockout mice have elevated baseline blood pressure and enhanced hypertension-induced renal damage compared with wild-type controls. Thus, the aim of this study was to determine the mechanism and functional significance of this increased hypertension-induced renal damage. We previously demonstrated by telemetric recording that the deoxycorticosterone–salt protocol produces a 35% increase in mean arterial pressure in both {alpha}-calcitonin gene-related peptide knockout and wild-type mice. Both strains of mice were studied at 0, 14, and 21 days after deoxycorticosterone–salt hypertension. Renal sections from hypertensive wild-type mice showed no pathological changes at any time point studied. However, on days 14 and 21, hypertensive knockout mice displayed progressive increases in glomerular proliferation, crescent formation, and tubular protein casts, as well as the inflammatory markers intercellular adhesion molecule-1, vascular adhesion molecule-1, and monocyte chemoattractant protein-1. There was a significant increase in 24-hour urinary isoprostane, a marker of oxidative stress-induced lipid peroxidation, levels at days 14 and 21 in the hypertensive knockout compared with hypertensive wild-type mice. Urinary microalbumin was significantly higher (2-fold) at day 21 and creatinine clearance was significantly decreased 4-fold in the hypertensive knockout compared with hypertensive wild-type mice. Therefore, in the absence of {alpha}-calcitonin gene-related peptide, deoxycorticosterone–salt hypertension induces enhanced oxidative stress, inflammation, and renal histopathologic damage, resulting in reduced renal function. Thus, sensory nerves, via {alpha}-calcitonin gene-related peptide, appear to be renoprotective against hypertension-induced damage.


Key Words: calcitonin gene-related peptide • hypertension • kidney




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
T. Ditting, G. Tiegs, K. Rodionova, P. W. Reeh, W. Neuhuber, W. Freisinger, and R. Veelken
Do distinct populations of dorsal root ganglion neurons account for the sensory peptidergic innervation of the kidney?
Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1427 - F1434.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Huang, A. Karve, I. Shah, M. C. Bowers, D. J. DiPette, S. C. Supowit, and G. S. Abela
Deletion of the mouse {alpha}-calcitonin gene-related peptide gene increases the vulnerability of the heart to ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1291 - H1297.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Wang, A. F. Chen, and D. H. Wang
Enhanced oxidative stress in kidneys of salt-sensitive hypertension: role of sensory nerves
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H3136 - H3143.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Tsuda, M. C. Bowers, K. A. Katki, A. Rao, M. Koehler, P. Patel, A. Spiekerman, D. J. DiPette, and S. C. Supowit
Calcitonin Gene-Related Peptide and Sympathetic Nervous System in Hypertension-Induced Renal Damage
Hypertension, December 1, 2005; 46(6): e23 - e24.
[Full Text] [PDF]